Results 151 to 160 of about 44,049 (225)

Predictors of Symptom Scores in Myeloproliferative Neoplasms: A Real-World Retrospective Cohort Study. [PDF]

Cancer Med
Khan MA, Naqvi SAA, Camoriano JK, Arana Yi CY, Andres JT, Blocher JL, Kosiorek HE, Riaz IB, Palmer JM.   +8 more
europepmc   +1 more source

Clinical and hematological profile of patients with philadelphia-negative myeloproliferative neoplasms: First report from the Ecuadorian registry. [PDF]

Hematol Transfus Cell Ther
Freire C, Noboa A, Acosta G, León C, Chiang-Wong H, Buenaño M, Loachamin R, Santana P, Huamán-Garaicoa F.   +8 more
europepmc   +1 more source

CD34-positive circulating cells quantification during follow-up in myeloproliferative neoplasms. [PDF]

Ann Hematol
Demoy M, Bauvais M, Vely A, Nicol T, Riou J, Le Jeanne H, Bauduin A, Rambaud H, Boyer F, Geneviève F, Boussaroque A, Copin MC, Ugo V, Orvain C, Luque Paz D.   +14 more
europepmc   +1 more source

Contraception in Myeloproliferative Neoplasms: A Pharmacological Review. [PDF]

Eur J Haematol
Alshurafa A, Benkhadra M, Babiker AM, Mohammed WM, Yassin MA.   +4 more
europepmc   +1 more source

Somatic mutations of calreticulin in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms

Haematologica, 2014
Luca Malcovati, Elisa Rumi, Mario Cazzola   +2 more
doaj   +1 more source

Advances in the Diagnosis and Treatment of Myeloproliferative Neoplasms (MPNs). [PDF]

Cancers (Basel)
Ma X, Zhou Z, Gu S, Guo Y, Zhou T, Shao R, Yan J, Chen W, Shi X.   +8 more
europepmc   +1 more source

Loss of life expectancy in patients with myeloproliferative neoplasms in Sweden. [PDF]

Haematologica
Leontyeva Y, Landtblom AR, Hultcrantz M, Lambe M, Bower H, Lambert PC, Andersson TM.   +6 more
europepmc   +1 more source

Clinical and disease characteristics from REVEAL at time of enrollment (baseline): Prospective observational study of patients with polycythemia vera in the United States [PDF]

, 2018
Boccia, Ralph V, Colucci, Philomena, Grunwald, Michael R, Mesa, Ruben, Oh, Stephen T, Paranagama, Dilan, Parasuraman, Shreekant, Stein, Brady L   +7 more
core   +1 more source

Immature Platelet Fraction as a Potential Biomarker of Dysregulated Thrombopoiesis in Philadelphia-Negative Myeloproliferative Neoplasms. [PDF]

J Clin Med
Zekanovic I, Marketin T, Moric Peric M, Zekanovic D, Vulic A, Milos M, Bogic A, Marcinkovic M, Grbic Pavlovic P, Radic Antolic M, Knezevic J, Jurlina L, Boban A.   +12 more
europepmc   +1 more source

Plasma cfDNA and peripheral blood gDNA provide complementary information for molecular monitoring in myeloproliferative neoplasms. [PDF]

Front Oncol
Ma X, Yang C, Duan Y, Zhang H, Tang X, Zhang Q, Qin W, Zhang W, Tang G, Guan M, Wu Z.   +10 more
europepmc   +1 more source